Integration of virtual and physical screening.

Area of Science:

• Drug discovery and medicinal chemistry
• Computational chemistry and cheminformatics
• Biotechnology and pharmaceutical sciences

Background:

• High-throughput screening (HTS) is the primary method for identifying novel drug lead compounds.
• HTS involves physically screening vast chemical libraries against biological targets.
• Virtual screening (VS) offers an alternative computational approach to evaluate chemical libraries *in silico*.

Purpose of the Study:

• To investigate the integration of physical screening (PS) and virtual screening (VS) strategies.
• To enhance the efficiency and focus of the lead compound identification process.
• To leverage both experimental and computational approaches in drug discovery.

Main Methods:

• Utilizing established high-throughput screening protocols.
• Implementing virtual screening techniques for *in silico* library evaluation.
• Developing an integrated workflow combining PS and VS.

Main Results:

• Demonstrated the feasibility of integrating PS and VS methodologies.
• Showcased how VS can refine and focus the PS process.
• Identified potential improvements in hit identification rates through integration.

Conclusions:

• The integration of VS with PS offers a synergistic approach to drug discovery.
• This combined strategy can optimize resource allocation and accelerate lead compound identification.
• Further research into integrated screening workflows is warranted for pharmaceutical development.